• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-1BB配体诱导细胞分裂、维持存活,并以相似的效力增强CD4和CD8 T细胞的效应功能。

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.

作者信息

Cannons J L, Lau P, Ghumman B, DeBenedette M A, Yagita H, Okumura K, Watts T H

机构信息

Department of Immunology, University of Toronto, Toronto, Ontario, Canada, M5S 1A8.

出版信息

J Immunol. 2001 Aug 1;167(3):1313-24. doi: 10.4049/jimmunol.167.3.1313.

DOI:10.4049/jimmunol.167.3.1313
PMID:11466348
Abstract

A costimulatory member of the TNFR family, 4-1BB, is expressed on activated T cells. Although some reports have suggested that 4-1BB is primarily involved in CD8 T cell activation, in this report we demonstrate that both CD4 and CD8 T cells respond to 4-1BB ligand (4-1BBL) with similar efficacy. CD4 and CD8 TCR transgenic T cells up-regulate 4-1BB, OX40, and CD27 and respond to 4-1BBL-mediated costimulation during a primary response to peptide Ag. 4-1BBL enhanced proliferation, cytokine production, and CTL effector function of TCR transgenic T cells. To compare CD4 vs CD8 responses to 4-1BBL under similar conditions of antigenic stimulation, we performed MLRs with purified CD4 or CD8 responders from CD28(+/+) and CD28(-/-) mice. We found that CD8 T cells produced IL-2 and IFN-gamma in a 4-1BBL-dependent manner, whereas under the same conditions the CD4 T cells produced IL-2 and IL-4. 4-1BBL promoted survival of CD4 and CD8 T cells, particularly at late stages of the MLR. CD4 and CD8 T cells both responded to anti-CD3 plus s4-1BBL with a similar cytokine profile as observed in the MLR. CD4 and CD8 T cells exhibited enhanced proliferation and earlier cell division when stimulated with anti-CD3 plus anti-CD28 compared with anti-CD3 plus 4-1BBL, and both subsets responded comparably to anti-CD3 plus 4-1BBL. These data support the idea that CD28 plays a primary role in initial T cell expansion, whereas 4-1BB/4-1BBL sustains both CD4 and CD8 T cell responses, as well as enhances cell division and T cell effector function.

摘要

肿瘤坏死因子受体(TNFR)家族的共刺激成员4-1BB在活化的T细胞上表达。尽管一些报告表明4-1BB主要参与CD8 T细胞活化,但在本报告中我们证明CD4和CD8 T细胞对4-1BB配体(4-1BBL)的反应具有相似的效力。CD4和CD8 TCR转基因T细胞上调4-1BB、OX40和CD27,并在对肽抗原的初次反应中对4-1BBL介导的共刺激作出反应。4-1BBL增强了TCR转基因T细胞的增殖、细胞因子产生和CTL效应功能。为了在相似的抗原刺激条件下比较CD4和CD8对4-1BBL的反应,我们用来自CD28(+/+)和CD28(-/-)小鼠的纯化CD4或CD8应答细胞进行了混合淋巴细胞反应(MLR)。我们发现CD8 T细胞以4-1BBL依赖的方式产生IL-2和IFN-γ,而在相同条件下CD4 T细胞产生IL-2和IL-4。4-1BBL促进了CD4和CD8 T细胞的存活,尤其是在MLR的后期。CD4和CD8 T细胞对抗CD3加s4-1BBL的反应与在MLR中观察到的细胞因子谱相似。与抗CD3加4-1BBL相比,用抗CD组3加抗CD28刺激时,CD4和CD8 T细胞表现出增强的增殖和更早的细胞分裂,并且两个亚群对抗CD3加4-1BBL的反应相当。这些数据支持这样的观点,即CD28在初始T细胞扩增中起主要作用,而4-1BB/4-1BBL维持CD4和CD8 T细胞反应,以及增强细胞分裂和T细胞效应功能。

相似文献

1
4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.4-1BB配体诱导细胞分裂、维持存活,并以相似的效力增强CD4和CD8 T细胞的效应功能。
J Immunol. 2001 Aug 1;167(3):1313-24. doi: 10.4049/jimmunol.167.3.1313.
2
4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.4-1BB配体介导的人T细胞共刺激可诱导CD4和CD8 T细胞扩增、细胞因子产生以及细胞溶解效应功能的发展。
J Immunol. 2002 May 15;168(10):4897-906. doi: 10.4049/jimmunol.168.10.4897.
3
4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.4-1BB和OX40独立发挥作用,以促进强大的CD8和CD4记忆反应。
J Immunol. 2004 Nov 15;173(10):5944-51. doi: 10.4049/jimmunol.173.10.5944.
4
Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.4-1BB与CD28介导的共刺激的时间分离:4-1BB配体在初次应答后期影响T细胞数量,并调节流感感染后T细胞记忆应答的规模。
J Immunol. 2002 Apr 15;168(8):3777-85. doi: 10.4049/jimmunol.168.8.3777.
5
Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.对4-1BB配体(4-1BBL)缺陷小鼠以及同时缺乏4-1BBL和CD28的小鼠进行分析,结果显示4-1BBL在皮肤同种异体移植排斥反应以及对流感病毒的细胞毒性T细胞反应中发挥作用。
J Immunol. 1999 Nov 1;163(9):4833-41.
6
4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.4-1BB配体是肿瘤坏死因子家族的一员,对于抗病毒CD8 T细胞反应的产生至关重要。
J Immunol. 1999 Nov 1;163(9):4859-68.
7
CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.4-1BB配体对静息T细胞的不依赖CD28、依赖TRAF2的共刺激作用。
J Exp Med. 1998 Jun 1;187(11):1849-62. doi: 10.1084/jem.187.11.1849.
8
Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo.4-1BB在体内CD4与CD8 T细胞应答过程中的表达及功能
Eur J Immunol. 2004 Mar;34(3):743-751. doi: 10.1002/eji.200324278.
9
A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.在体内原发性与继发性CD8 T细胞对流感的反应过程中,共刺激从CD28向4-1BB的转变。
J Immunol. 2004 Jan 15;172(2):981-8. doi: 10.4049/jimmunol.172.2.981.
10
Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.4-1BB(CDw137)的结扎调节异基因骨髓移植受者的移植物抗宿主病、移植物抗白血病和移植物排斥反应。
J Immunol. 2001 Mar 1;166(5):3174-83. doi: 10.4049/jimmunol.166.5.3174.

引用本文的文献

1
Evaluation of immune microenvironment in non-small cell lung carcinoma after neoadjuvant immunotherapy: a case report.新辅助免疫治疗后非小细胞肺癌免疫微环境的评估:一例报告
Int J Clin Exp Pathol. 2025 Jul 15;18(7):405-413. doi: 10.62347/NCYZ7977. eCollection 2025.
2
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms.未接种疫苗的有持续症状的新冠病毒感染者的多层深度免疫分析、新冠病毒血症和炎症
Commun Med (Lond). 2025 May 5;5(1):155. doi: 10.1038/s43856-025-00832-8.
3
Immunological Network Signature of Naïve Non-Oncogene-Addicted Non-Small Cell Lung Cancer Patients Treated with Anti-PD1 Therapy: A Pilot Study.
接受抗PD1治疗的初治非癌基因成瘾性非小细胞肺癌患者的免疫网络特征:一项初步研究。
Cancers (Basel). 2025 Mar 8;17(6):922. doi: 10.3390/cancers17060922.
4
MD Simulation Reveals a Trimerization-Enhanced Interaction of CD137L with CD137.分子动力学模拟揭示了CD137L与CD137三聚化增强的相互作用。
Int J Mol Sci. 2025 Feb 22;26(5):1903. doi: 10.3390/ijms26051903.
5
ATLAS-seq: a microfluidic single-cell TCR screen for antigen-reactive TCRs.ATLAS-seq:一种用于抗原反应性T细胞受体的微流控单细胞TCR筛选方法
Nat Commun. 2025 Jan 2;16(1):216. doi: 10.1038/s41467-024-54675-3.
6
Anti-PD1 therapies induce an early expansion of Ki67CD8 T cells in metastatic non-oncogene addicted NSCLC patients.抗程序性死亡蛋白1(PD1)疗法可诱导转移性非癌基因成瘾性非小细胞肺癌(NSCLC)患者体内Ki67阳性CD8 T细胞的早期扩增。
Front Immunol. 2024 Dec 18;15:1483182. doi: 10.3389/fimmu.2024.1483182. eCollection 2024.
7
Application of deep learning models on single-cell RNA sequencing analysis uncovers novel markers of double negative T cells.深度学习模型在单细胞RNA测序分析中的应用揭示了双阴性T细胞的新标志物。
Sci Rep. 2024 Dec 28;14(1):31158. doi: 10.1038/s41598-024-82406-7.
8
Fat-to-blood recirculation of partially dysfunctional PD-1CD4 Tconv cells is associated with dysglycemia in human obesity.部分功能失调的PD-1 CD4调节性T细胞从脂肪到血液的再循环与人类肥胖中的血糖异常有关。
iScience. 2024 Feb 1;27(3):109032. doi: 10.1016/j.isci.2024.109032. eCollection 2024 Mar 15.
9
4-1BB immunotherapy: advances and hurdles.4-1BB 免疫疗法:进展与障碍。
Exp Mol Med. 2024 Feb;56(1):32-39. doi: 10.1038/s12276-023-01136-4. Epub 2024 Jan 4.
10
In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4 T cells.在黑色素瘤中使用 IL-15/IL-15Rα 和 PD-L1 拮抗剂进行局部基因治疗的体外建模揭示了 NK 细胞和 CD4 T 细胞之间的相互作用。
Sci Rep. 2023 Nov 3;13(1):18995. doi: 10.1038/s41598-023-45948-w.